Clinical Outcomes Of Mpox Infection Following Treatment With Tecovirimat Similar Between Patients With HIV Infection, Those Without Immunocompromised Conditions, Study Finds
December 06, 2023
Infectious Disease Advisor (12/5, Chan) reports, “Clinical outcomes of mpox infection following treatment with tecovirimat are similar between patients with HIV infection and those without immunocompromised conditions,” according to a study. The findings were published in Open Forum Infectious Diseases.